What Is the CHA₂DS₂-VASc Score?

The CHA₂DS₂-VASc score is the internationally validated tool for estimating annual stroke risk in patients with non-valvular atrial fibrillation (AF). Developed by Lip et al. in 2010 as a refinement of the original CHADS₂ score, it is now the primary anticoagulation decision tool in ESC, AHA/ACC, and CCS guidelines.

The acronym stands for:

• •C — Congestive heart failure (1 point)
• •H — Hypertension (1 point)
• •A₂ — Age ≥ 75 years (2 points)
• •D — Diabetes mellitus (1 point)
• •S₂ — Prior Stroke/TIA/thromboembolism (2 points)
• •V — Vascular disease (MI, PAD, aortic plaque) (1 point)
• •A — Age 65–74 years (1 point)
• •Sc — Sex category: Female (1 point)

Maximum score: 9 points

---

Step-by-Step Scoring Guide

Step 1 — Congestive Heart Failure (C) — 1 Point

Score 1 point if the patient has:

• •Moderate-to-severe systolic dysfunction (LVEF < 40%)
• •Recent decompensated heart failure requiring hospitalisation
• •Hypertrophic cardiomyopathy

Clinical tip: Preserved EF heart failure (HFpEF) is debated — most guidelines include it. When in doubt, score it.

---

Step 2 — Hypertension (H) — 1 Point

Score 1 point if the patient has:

• •Resting BP > 140/90 mmHg on two separate occasions
• •Currently on antihypertensive medication (regardless of current BP control)

Clinical tip: Controlled hypertension on medication still scores 1 point. The risk factor is the underlying condition, not the current BP reading.

---

Step 3 — Age ≥ 75 Years (A₂) — 2 Points

Score 2 points if age ≥ 75. This is the highest single-variable weight in the score, reflecting the exponential increase in stroke risk with advanced age.

Clinical tip: Age ≥ 75 is the most powerful modifiable anticoagulation trigger. A patient with no other risk factors but age ≥ 75 has a CHA₂DS₂-VASc of 2 — anticoagulation is recommended.

---

Step 4 — Diabetes Mellitus (D) — 1 Point

Score 1 point if the patient has:

• •Type 1 or Type 2 diabetes mellitus
• •Fasting glucose > 125 mg/dL (7 mmol/L) on treatment

Clinical tip: Pre-diabetes does not score. Impaired fasting glucose alone is not sufficient.

---

Step 5 — Prior Stroke/TIA/Thromboembolism (S₂) — 2 Points

Score 2 points if the patient has a history of:

• •Ischaemic stroke
• •Transient ischaemic attack (TIA)
• •Systemic thromboembolism (peripheral arterial embolism)

Clinical tip: This is the single most important risk factor. A prior stroke doubles the annual recurrence risk. Any patient with AF + prior stroke has a minimum CHA₂DS₂-VASc of 2 — anticoagulation is mandatory unless there is a clear contraindication.

---

Step 6 — Vascular Disease (V) — 1 Point

Score 1 point if the patient has:

• •Prior myocardial infarction (MI)
• •Peripheral arterial disease (PAD)
• •Aortic plaque on imaging

Clinical tip: Coronary artery disease without prior MI does not score. The criterion requires documented vascular disease, not just risk factors.

---

Step 7 — Age 65–74 Years (A) — 1 Point

Score 1 point if age is 65–74. Note that age ≥ 75 scores 2 points (Step 3), not 1+1. These are mutually exclusive age categories.

---

Step 8 — Sex Category: Female (Sc) — 1 Point

Score 1 point if the patient is female.

Critical nuance: The female sex modifier is a risk modifier, not an independent risk factor. ESC 2020 guidelines clarify that female sex alone (CHA₂DS₂-VASc = 1 in a woman) does not trigger anticoagulation. Anticoagulation is recommended for women with a score ≥ 2 (i.e., at least one additional clinical risk factor beyond sex).

---

Try the Live CHA₂DS₂-VASc Calculator

Calculate your patient's stroke risk and anticoagulation recommendation in real time:

---

Score Interpretation and Annual Stroke Risk

---

Choosing the Right Anticoagulant

DOACs vs. Warfarin

For non-valvular AF, DOACs are preferred over warfarin in all major guidelines (ESC 2020, AHA/ACC 2023):

Warfarin remains indicated for:

• •Mechanical heart valves
• •Moderate-to-severe mitral stenosis (rheumatic)
• •Antiphospholipid syndrome (triple-positive)

When to Use Warfarin Over DOACs

---

The HAS-BLED Counterbalance

Before prescribing anticoagulation, always assess bleeding risk with the HAS-BLED score:

HAS-BLED ≥ 3 = high bleeding risk. This is NOT a contraindication to anticoagulation — it identifies modifiable risk factors to address and patients requiring closer monitoring. Key principle: In most patients with AF and CHA₂DS₂-VASc ≥ 2, the stroke prevention benefit of anticoagulation outweighs the bleeding risk. The HAS-BLED score should prompt risk factor modification, not anticoagulation avoidance.

---

Special Populations

AF in CKD

• •eGFR 30–50: Dose-reduce rivaroxaban (15 mg OD) and edoxaban (30 mg OD)
• •eGFR 15–30: Apixaban preferred (least renal clearance, ~27%)
• •eGFR < 15 / Dialysis: Limited DOAC data — warfarin or apixaban with close monitoring
• •Avoid dabigatran if eGFR < 30 (80% renal clearance)

AF in the Elderly (≥ 80 Years)

• •Age ≥ 75 scores 2 points — almost all elderly AF patients qualify for anticoagulation
• •Dabigatran 110 mg BD preferred over 150 mg BD in age ≥ 80
• •Apixaban has the most favourable bleeding profile in elderly patients (ARISTOTLE subgroup)
• •Fall risk alone is NOT a contraindication — a patient would need to fall ~300 times/year for fall risk to outweigh stroke prevention benefit

AF in Pregnancy

• •Warfarin: Teratogenic in first trimester (warfarin embryopathy)
• •LMWH (enoxaparin): Preferred throughout pregnancy
• •DOACs: Contraindicated in pregnancy (limited safety data)

---

CHA₂DS₂-VASc vs. CHADS₂: Why the Upgrade?

The key advantage of CHA₂DS₂-VASc is better identification of truly low-risk patients (score 0 in males) who can safely avoid anticoagulation, while capturing additional moderate-risk patients who benefit from treatment.

---

Common Scoring Errors

1. Counting female sex as an independent risk factor

Female sex is a risk modifier. A woman with CHA₂DS₂-VASc = 1 (sex only) does not require anticoagulation per ESC 2020 guidelines.

2. Not scoring controlled hypertension

Hypertension on medication still scores 1 point. The risk factor is the underlying condition.

3. Confusing age categories

Age 65–74 = 1 point. Age ≥ 75 = 2 points. These are mutually exclusive — do not add both.

4. Missing vascular disease

Aortic plaque on echocardiography or CT counts as vascular disease. Don't limit this to MI and PAD.

5. Using CHA₂DS₂-VASc for valvular AF

CHA₂DS₂-VASc applies to non-valvular AF only. Patients with mechanical valves or moderate-severe mitral stenosis require warfarin regardless of score.

---

Key References

• •Lip GY et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. *Chest.* 2010;137(2):263–272.
• •Hindricks G et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. *Eur Heart J.* 2021;42(5):373–498.
• •January CT et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. *J Am Coll Cardiol.* 2019;74(1):104–132.